MedTrace Logo

Iron Status and Myelination in Premature Infants

NCT00684697 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-03-02

No results posted yet for this study

Summary

Premature infants with iron deficiency if supplemented with more elemental iron than the routine 2mg/kg/day will have improved brain development.

Conditions

  • Neurodevelopmental Outcome

Interventions

DIETARY_SUPPLEMENT

iron

High, intermediate and low iron dosage orally for 2 months

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Sanjiv B Amin, MD MS · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2015-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00684697 on ClinicalTrials.gov